Ghoussaini Racha, Zareef Rana, Makarem Adham, Younis Nour, Al Hassan Sally, El Rassi Issam, Obeid Munir, Bitar Fadi, Arabi Mariam
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Department of Pediatric and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Front Cardiovasc Med. 2024 Apr 29;11:1368921. doi: 10.3389/fcvm.2024.1368921. eCollection 2024.
Pulmonary artery banding serves as an important palliative procedure used for the management of several congenital heart lesions. This study aims to describe a 20-year experience of pulmonary artery banding at a tertiary care center in a developing country.
This is a retrospective chart review of patients who underwent pulmonary artery banding over a 20-year period between January 2000 and July 2020 in a tertiary care center in a developing country. Data regarding demographics, indications, diagnosis, echocardiographic findings, postoperative complications, hospital stay, and outcomes were recorded.
A total of 143 patients underwent pulmonary artery banding between 2000 and 2020, with a decrease from approximately 15 surgeries per year in 2012 to 1-2 surgeries a year in 2020. At the time of banding, the median age of patients was approximately 90 days [interquartile range, IQR, 30-150 days]. Four patients (2.8%) died during the band placement. No significant association was observed between baseline characteristics or type of heart defect at presentation and postoperative morbidity and mortality.
Pulmonary artery banding remains useful in a subset of congenital heart lesions and as a surgical palliation, with relatively low mortality, allowing postponement of total correction to a higher weight. This technique continues to be valuable in developing countries or for heart surgical programs with limited resources.
肺动脉环扎术是用于治疗多种先天性心脏病的重要姑息性手术。本研究旨在描述一个发展中国家三级医疗中心20年的肺动脉环扎术经验。
这是一项对2000年1月至2020年7月期间在一个发展中国家三级医疗中心接受肺动脉环扎术的患者进行的回顾性病历审查。记录了有关人口统计学、适应证、诊断、超声心动图检查结果、术后并发症、住院时间和结局的数据。
2000年至2020年期间共有143例患者接受了肺动脉环扎术,手术例数从2012年的每年约15例减少至2020年的每年1 - 2例。环扎时,患者的中位年龄约为90天[四分位间距,IQR,30 - 150天]。4例患者(2.8%)在环扎过程中死亡。术前的基线特征或心脏缺陷类型与术后发病率和死亡率之间未观察到显著关联。
肺动脉环扎术在一部分先天性心脏病中仍然有用,作为一种手术姑息治疗,死亡率相对较低,可将完全矫正推迟到更高体重时进行。这项技术在发展中国家或资源有限的心脏外科项目中仍然具有价值。